Latest Breaking News On - John reynders - Page 4 : comparemela.com

Neumora Therapeutics unveiled $500 million in capital and a research partnership with Amgen. The startup analyzes neurological data to inform its drug research and development; President and Chief Operating Officer Lori Lyons-Williams said researching psychiatric drugs and neurodegenerative drugs within the same company allows brain insights from one area to inform the other.

Al iskandariyahPaul bernsJohn reyndersLori lyons williamsScripps research instituteSoftbank vision fundNeumora therapeuticsMassachusetts based neumoraBlackthorn therapeuticsAlexandria venture investmentsAltitude life science venturesCatalio capital managementF prime capitalLogos capitalMubadala capitalNewpath partners